litlas
Log inCreate account

Robert A. Wolff

Active 1984–2025

188
Papers
40,065
Citations
105
h-index
183
i10-index

Citations

Citations per year for Robert A. Wolff1985: 1 citations1986: 3 citations1987: 1 citations1988: 4 citations1991: 3 citations1992: 2 citations1993: 3 citations1994: 2 citations1995: 13 citations1996: 42 citations1997: 34 citations1998: 31 citations1999: 33 citations2000: 29 citations2001: 46 citations2002: 46 citations2003: 35 citations2004: 64 citations2005: 110 citations2006: 161 citations2007: 182 citations2008: 225 citations2009: 310 citations2010: 350 citations2011: 354 citations2012: 394 citations2013: 414 citations2014: 324 citations2015: 342 citations2016: 328 citations2017: 315 citations2018: 299 citations2019: 1,103 citations2020: 1,386 citations2021: 1,199 citations2022: 897 citations2023: 689 citations2024: 1,099 citations2025: 506 citations2026: 21 citations1989–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,839 citing papers, 27.9% of this breakdownChina: 1,516 citing papers, 11% of this breakdownItaly: 880 citing papers, 6.4% of this breakdownGermany: 743 citing papers, 5.4% of this breakdownUnited Kingdom: 642 citing papers, 4.7% of this breakdownJapan: 639 citing papers, 4.6% of this breakdownFrance: 530 citing papers, 3.9% of this breakdownNetherlands: 408 citing papers, 3% of this breakdownCanada: 367 citing papers, 2.7% of this breakdownSpain: 367 citing papers, 2.7% of this breakdownSouth Korea: 353 citing papers, 2.6% of this breakdownAustralia: 321 citing papers, 2.3% of this breakdown
0%27.9%Other 22.8%

Institutions

Fields

  • Medicine71.3%
  • Biochemistry, Genetics and Molecular Biology22.5%
  • Immunology and Microbiology2%
  • Engineering0.8%
  • Materials Science0.6%
  • Physics and Astronomy0.4%
  • Other2.4%

Topics

  • Pancreatic and Hepatic Oncology Research13.5%
  • Cholangiocarcinoma and Gallbladder Cancer Studies4.6%
  • Cancer Genomics and Diagnostics3.4%
  • Pancreatitis Pathology and Treatment3.2%
  • Neuroendocrine Tumor Research Advances2.9%
  • Colorectal Cancer Treatments and Studies2.5%
  • Other69.9%

Coauthors

All papers

Open in search
  1. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary, Stephen W. Behrman, Al B. Benson, Dana B. Cardin, E. Gabriela Chiorean, Vincent Chung, Brian G. Czito, Marco Del Chiaro, Mary Dillhoff, Timothy R. Donahue, Efrat Dotan, Cristina R. Ferrone, Christos Fountzilas, Jeffrey M. Hardacre, William G. Hawkins, Kelsey Klute, Andrew H. Ko, John W. Kunstman, Noelle K. LoConte, Andrew M. Lowy, Cassadie Moravek, Eric K. Nakakura, Amol Narang, Jorge Obando, Patricio M. Polanco, Sushanth Reddy, Marsha Reyngold, Courtney L. Scaife, Jeanne Shen, Charles M. Vollmer, Robert A. Wolff, Brian M. Wolpin, Beth Lynn, Giby V. George - Journal of the National Comprehensive Cancer Network 2021 cited by 1,286

  2. Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

    Authors: Lacey Padrón, Deena M. Maurer, Mark H. O’Hara, Eileen M. O’Reilly, Robert A. Wolff, Zev A. Wainberg, Andrew H. Ko, George A. Fisher, Osama E. Rahma, Jaclyn P. Lyman, Christopher R. Cabanski, Jia Xin Yu, Shannon M. Pfeiffer, Marko Spasić, Jingying Xu, Pier Federico Gherardini, Joyson Karakunnel, Rosemarie Mick, Cécile Alanio, Katelyn T. Byrne, Travis J. Hollmann, Jonni S. Moore, Derek D. Jones, Marco Tognetti, Richard Chen, Xiaodong Yang, Lisa Salvador, E. John Wherry, Ute Dugan, Jill O’Donnell-Tormey, Lisa H. Butterfield, Vanessa M. Hubbard-Lucey, Ramy Ibrahim, Justin Fairchild, Samantha Bucktrout, Theresa LaVallee, Robert H. Vonderheide - Nature Medicine 2022 cited by 350

  3. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

    Authors: Malcolm J. Moore, David Goldstein, John Hamm, Arié Figer, J. Randolph Hecht, Steven Gallinger, H. Au, P. Murawa, David Walde, Robert A. Wolff, Daniel de Castro, Robert Lim, Keyue Ding, Gary M. Clark, Theodora Voskoglou-Nomikos, Mieke Ptasynski, Wendy R. Parulekar - Journal of Clinical Oncology 2007 cited by 3,859

  4. Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

    Authors: Ahmed O. Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean‐Nicolas Vauthey, Sunyoung S. Lee, Betül Gök Yavuz, Yehia I. Mohamed, Aliya Qayyum, Sonali Jindal, Fei Duan, Sreyashi Basu, Shalini S. Yadav, Courtney Nicholas, Jing Sun, Kanwal Raghav, Asif Rashid, Kristen Carter, Yun Shin Chun, Ching‐Wei D. Tzeng, Divya Sakamuri, Li Xu, Ryan Sun, Vittorio Cristini, Laura Beretta, James C. Yao, Robert A. Wolff, James P. Allison, Padmanee Sharma - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 256

  5. CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study

    Authors: Mark H. O’Hara, Eileen M. O’Reilly, Gauri R. Varadhachary, Robert A. Wolff, Zev A. Wainberg, Andrew H. Ko, George A. Fisher, Osama E. Rahma, Jaclyn P. Lyman, Christopher R. Cabanski, Rosemarie Mick, Pier Federico Gherardini, Lacey J. Kitch, Jingying Xu, Theresa Samuel, Joyson Karakunnel, Justin Fairchild, Samantha Bucktrout, Theresa LaVallee, Cheryl Selinsky, Jacob E. Till, Erica L. Carpenter, Cécile Alanio, Katelyn T. Byrne, Richard O Chen, Ovid Trifan, Ute Dugan, Christine E. Horak, Vanessa M. Hubbard-Lucey, E. John Wherry, Ramy Ibrahim, Robert H. Vonderheide - The Lancet Oncology 2020 cited by 301

  6. Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

    Authors: Navneet K. Dhillon, Bharat B. Aggarwal, Robert A. Newman, Robert A. Wolff, Ajaikumar B. Kunnumakkara, James L. Abbruzzese, Chaan S. Ng, Vladimir Badmaev, Razelle Kurzrock - Clinical Cancer Research 2008 cited by 1,318

  7. Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers

    Authors: Rachna T. Shroff, Milind Javle, Lianchun Xiao, Ahmed O. Kaseb, Gauri R. Varadhachary, Robert A. Wolff, Kanwal Raghav, Michiko Iwasaki, Peter Masci, Ramesh K. Ramanathan, Daniel H. Ahn, Tanios Bekaii‐Saab, Mitesh J. Borad - JAMA Oncology 2019 cited by 473

  8. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients

    Authors: J. Castillo, Vincent Bernard, F. Anthony San Lucas, Kelvin Allenson, Michela Capello, D.U. Kim, Peter R. C. Gascoyne, Feven C. Mulu, Bret M. Stephens, Jonathan Huang, H. Wang, Amin A. Momin, Rodrigo Jácamo, Matthew H. G. Katz, Robert A. Wolff, Milind Javle, Gauri R. Varadhachary, Ignacio I. Wistuba, Samir Hanash, Anirban Maitra, Héctor M. Álvarez - Annals of Oncology 2017 cited by 271

  9. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

    Authors: Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary, Horacio J. Asbun, Andrew Bain, Stephen W. Behrman, Al B. Benson, Ellen F. Binder, Dana B. Cardin, Charles Cha, E. Gabriela Chiorean, Vincent Chung, Brian G. Czito, Mary Dillhoff, Efrat Dotan, Cristina R. Ferrone, Jeffrey M. Hardacre, William G. Hawkins, Joseph M. Herman, Andrew H. Ko, Srinadh Komanduri, Albert C. Koong, Noelle K. LoConte, Andrew M. Lowy, Cassadie Moravek, Eric K. Nakakura, Eileen M. O’Reilly, Jorge Obando, Sushanth Reddy, Courtney L. Scaife, Sarah P. Thayer, Colin D. Weekes, Robert A. Wolff, Brian M. Wolpin, Jennifer L. Burns, Susan Darlow - Journal of the National Comprehensive Cancer Network 2017 cited by 1,030

  10. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer

    Authors: Vincent Bernard, Dong U. Kim, F. Anthony San Lucas, Jonathan Castillo, Kelvin Allenson, Feven C. Mulu, Bret M. Stephens, Jonathan Huang, Alexander Semaan, Paola A. Guerrero, Nabiollah Kamyabi, Jun Zhao, Mark W. Hurd, Eugene J. Koay, Cullen M. Taniguchi, Joseph M. Herman, Milind Javle, Robert A. Wolff, Matthew H. G. Katz, Gauri R. Varadhachary, Anirban Maitra, Hector A. Alvarez - Gastroenterology 2018 cited by 371

  11. Survival improvement for patients with metastatic colorectal cancer over twenty years

    Authors: Fadl A. Zeineddine, Mohammad A. Zeineddine, Abdelrahman Yousef, Yue Gu, Saikat Chowdhury, Arvind Dasari, Ryan Huey, Benny Johnson, Bryan K. Kee, Michael S. Lee, Maria Pia Morelli, Van K. Morris, Michael J. Overman, Christine M. Parseghian, Kanwal Raghav, Jason Willis, Robert A. Wolff, Yoshikuni Kawaguchi, Jean‐Nicolas Vauthey, Ryan Sun, Scott Kopetz, John Paul Shen - npj Precision Oncology 2023 cited by 174

  12. Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma

    Authors: Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, Kawther Abdilleh, Mark Knafl, Paul Edelkamp, Kristin Alfaro-Munoz, Ray Chacko, Jennifer Peterson, Brandon G. Smaglo, Robert A. Wolff, Shubham Pant, Michael S. Lee, Jason Willis, Michael J. Overman, Sudheer Doss, Lynn M. Matrisian, Mark W. Hurd, Rebecca A. Snyder, Matthew H. G. Katz, Huamin Wang, Anirban Maitra, John Paul Shen, Dan Zhao - npj Precision Oncology 2024 cited by 82

  13. Non-V600BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer

    Authors: Jeremy Jones, Lindsay A. Renfro, Humaid O. Al‐Shamsi, Alexa B. Schrock, Andrew Rankin, Ben Y. Zhang, Pashtoon Murtaza Kasi, Jesse S. Voss, Alexis D. Leal, James Sun, Jeffrey S. Ross, Siraj M. Ali, Joleen M. Hubbard, Benjamin R. Kipp, Robert R. McWilliams, Scott Kopetz, Robert A. Wolff, Axel Grothey - Journal of Clinical Oncology 2017 cited by 357

  14. Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential

    Authors: Marta Sans, Yuki Makino, Jimin Min, Kimal Rajapakshe, Michele Yip-Schneider, C. Max Schmidt, Mark W. Hurd, Jared K. Burks, Javier A. Gomez, Fredrik I. Thege, Johannes F. Fahrmann, Robert A. Wolff, Michael P. Kim, Paola A. Guerrero, Anirban Maitra - Cancer Discovery 2023 cited by 59

  15. Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

    Authors: Gauri R. Varadhachary, Eric P. Tamm, James L. Abbruzzese, Henry Q. Xiong, Christopher H. Crane, Huamin Wang, Jeffrey E. Lee, Peter W. T. Pisters, Douglas B. Evans, Robert A. Wolff - Annals of Surgical Oncology 2006 cited by 874

  16. Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications

    Authors: Chaitanya Churi, Rachna T. Shroff, Ying Wang, Asif Rashid, Hyunseon C. Kang, J. Weatherly, Mingxin Zuo, Ralph Zinner, David S. Hong, Funda Meric‐Bernstam, Filip Jankú, Christopher H. Crane, Lopa Mishra, J.N. Vauthey, Robert A. Wolff, Gordon B. Mills, Milind Javle - PLoS ONE 2014 cited by 454

  17. Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

    Authors: Matthew H. G. Katz, Peter W. T. Pisters, Douglas B. Evans, Charlotte C. Sun, Jeffrey E. Lee, Jason B. Fleming, Nicolas J. Vauthey, Eddie K. Abdalla, Christopher H. Crane, Robert A. Wolff, Gauri R. Varadhachary, Rosa F. Hwang - Journal of the American College of Surgeons 2008 cited by 820

  18. Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

    Authors: Benny Johnson, Cara Haymaker, Edwin R. Parra, Luisa M. Solis Soto, Xuemei Wang, Jane V. Thomas, Arvind Dasari, Van K. Morris, Kanwal Raghav, Eduardo Vilar, Bryan K. Kee, Cathy Eng, Christine M. Parseghian, Robert A. Wolff, Younghee Lee, Daniele Lorenzini, Caddie Laberiano-Fernández, Anuj Verma, Wenhua Lang, Ignacio I. Wistuba, P. Andrew Futreal, Scott Kopetz, Michael J. Overman - Journal for ImmunoTherapy of Cancer 2022 cited by 52

  19. Pancreatic cancer

    Authors: Donghui Li, Keping Xie, Robert A. Wolff, James L. Abbruzzese - The Lancet 2004 cited by 1,713

  20. Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

    Authors: Giampaolo Perri, Laura Prakash, Wei Qiao, Gauri R. Varadhachary, Robert A. Wolff, David R. Fogelman, Michael J. Overman, Shubham Pant, Milind Javle, Eugene J. Koay, Joseph M. Herman, Michael P. Kim, Naruhiko Ikoma, Ching‐Wei D. Tzeng, Jeffrey E. Lee, Matthew H. G. Katz - JAMA Surgery 2020 cited by 179

  21. Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, BRAFV600E metastatic colorectal cancer.

    Authors: Van K. Morris, Christine M. Parseghian, Michelle Escano, Benny Johnson, Kanwal Raghav, Arvind Dasari, Ryan Huey, Michael J. Overman, Jason Willis, Michael Sangmin Lee, Robert A. Wolff, Bryan K. Kee, John Paul Shen, Maria Pia Morelli, Alda L. Tam, Wai Chin Foo, Lianchun Xiao, Scott Kopetz - Journal of Clinical Oncology 2022 cited by 78

  22. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

    Authors: Rodabe N. Amaria, Anne Knisely, David Vining, Scott Kopetz, Michael J. Overman, Milind Javle, Mara B. Antonoff, Ching‐Wei D. Tzeng, Robert A. Wolff, Shubham Pant, Kathryn Lito, Kelly Rangel, Bryan Fellman, Ying Yuan, Karen H. Lu, Donastas Sakellariou-Thompson, Cara Haymaker, Marie‐Andrée Forget, Patrick Hwu, Chantale Bernatchez, Amir A. Jazaeri - Journal for ImmunoTherapy of Cancer 2024 cited by 52

  23. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients

    Authors: Chirayu Mohindroo, Merve Hasanov, Jane E. Rogers, Wenli Dong, Laura R. Prakash, Seyda Baydogan, Jonathan D. Mizrahi, Michael J. Overman, Gauri R. Varadhachary, Robert A. Wolff, Milind Javle, David R. Fogelman, Michael T. Lotze, Michael P. Kim, Matthew H. G. Katz, Shubham Pant, Ching‐Wei D. Tzeng, Florencia McAllister - Cancer Medicine 2021 cited by 71

  24. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

    Authors: Van K. Morris, Mohamed E. Salem, Halla Nimeiri, Syma Iqbal, Preet Paul Singh, Kristen K. Ciombor, Blasé N. Polite, Dustin A. Deming, Emily Chan, James L. Wade, Lianchun Xiao, Tanios Bekaii‐Saab, Luis M. Vence, Jorge Blando, Armeen Mahvash, Wai Chin Foo, Chimela Ohaji, Manolo Pasia, Gail L. Bland, Aki Ohinata, Jane E. Rogers, Amir Mehdizadeh, Kimberly C. Banks, Richard B. Lanman, Robert A. Wolff, Howard Streicher, James P. Allison, Padmanee Sharma, Cathy Eng - The Lancet Oncology 2017 cited by 393